---
title: "Ventas Life Science & Healthcare Real Estate Fund, L.P. SEC filings"
url: https://altstreet.investments/edgar/1805621
kind: edgar-entity
updated: 2026-10-17
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# Ventas Life Science & Healthcare Real Estate Fund, L.P.: SEC filings and what they report

Ventas Life Science & Healthcare Real Estate Fund, L.P. is a Delaware-organized real estate investment fund that filed an amended Form D reporting $2,091.0 million raised in equity securities from 32 investors, with a $25.0 million minimum investment per investor. The offering relies on Rule 506(b) combined with a Section 3(c) Investment Company Act exclusion, consistent with a large institutional private real estate vehicle; no parent platform or sibling entities were identified in the dataset.

| Field | Value |
| --- | --- |
| Entity | Ventas Life Science & Healthcare Real Estate Fund, L.P. |
| CIK | 1805621 |
| Filing family | 506(b), 3(c) |
| Entity type | fund vehicle |
| Manager (as filed) | Ventas |
| Newest fact-bearing filing | October 16, 2026, accession 0001805621-26-000002 |
| Total sold (as reported) | $2,090,987,398 |
| Investors (as reported) | 32 |
| Minimum investment (as filed) | $25,000,000 |
| Vintage | 2026 |

## Related persons (Form D Item 3)

| Name | Relationship |
| --- | --- |
| N/A VLSHRE Fund GP, LLC | Director |
| Brian Newman | Executive Officer |
| Brian Wood | Executive Officer |
| Michael Smith | Executive Officer |


## Filings (7 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| October 16, 2026 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1805621/000180562126000002/ |
| October 17, 2025 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1805621/000180562125000002/ |
| October 21, 2024 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1805621/000180562124000001/ |
| March 3, 2023 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1805621/000180562123000001/ |
| March 4, 2022 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1805621/000180562122000001/ |
| March 12, 2021 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1805621/000180562121000001/ |
| March 12, 2020 | D | Form D | https://www.sec.gov/Archives/edgar/data/1805621/000180562120000001/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/1805621
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001805621&owner=include&count=40
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/1805621
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.
